Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.
Martina Barone,
Francesca Ricci,
Daria Sollazzo,
Emanuela Ottaviani,
Marco Romano,
Giuseppe Auteri,
Daniela Bartoletti,
Maria LB Reggiani,
Nicola Vianelli,
Pier L Tazzari,
Michele Cavo,
Dorian Forte,
Francesca Palandri,
Lucia Catani
OAI: oai:www.repository.cam.ac.uk:1810/292422 • DOI: 10.17863/CAM.39579